Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0YG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,881
Award facts
- Contract value 100% obligated
- $55,880.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,880.81 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds significant contracts supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The current delivery order for Entresto, a cardiac medication, exemplifies the company's role in fulfilling specific pharmaceutical needs within the broader federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FA0YG?
SPE2DR26FA0YG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FA0YG worth?
The government has obligated $55,881 on SPE2DR26FA0YG.
Is contract SPE2DR26FA0YG an order under another contract?
Yes. SPE2DR26FA0YG is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0YG competed?
The extent of competition for SPE2DR26FA0YG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award